Another Cash Deal: J&J’s Ethicon to Acquire Auris Health for $3.4 Billion
Ethicon, Inc., part of the Johnson & Johnson family, is acquiring robotic technology developer Auris Health, Inc. for about $3.4 billion in cash. With its current focus on lung cancer, Auris Health has an FDA-cleared platform for bronchoscopic diagnostic and therapeutic procedures.
“In this new era of health care, we’re aiming to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer,” said Ashley McEvoy, executive vice president, worldwide chairman, medical devices, at Johnson & Johnson in a press release. “We believe the combination of best-in-class robotics, advanced instrumentation and unparalleled end-to-end connectivity will make a meaningful difference in patient outcomes.”
The deal also compliments J&J’s acquisition of Orthotaxy’s robotic technology for orthopaedics, which occurred in February 2018, as well as its development of the Verb Surgical Platform (a partnership between J&J and Verily, formerly Google Life Sciences).
The transaction is expected to close by the end of Q2 this year.
Related Articles
-
Rapid developments in healthcare technology, combined with improved data collection, pandemic pressures and increased consumer demand for tech-enabled and virtual health care, are fueling innovation and transformation in the digital health space.
-
The AHRQ brief proposes a framework to assess the risk/safety, technical functionality and mental health features of apps. The framework can be used by advocacy organizations, payers, healthcare systems and others to inform selection of mental health mobile apps.
-
CVS Health has entered into a definitive agreement to acquire Signify Health, which boasts a network of more than 10,000 physicians, nurse practitioners and physician assistants that provide home-based visits.
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
